Skip to main content
  • English
  • Español
Oryzon
  • Company
    • Overview
    • Strategy
    • Team
  • Epigenetics
    • Epigenetics
    • LSD1
  • Programs
    • Pipeline
    • Iadademstat
    • Vafidemstat
    • Collaborations
    • Publications
  • Patients
    • Clinical Trials
  • Investors
    • Share Information
      • Share Performance
      • Shares and Capital Structure
      • Dividends
      • Share Issues
      • Takeover Bids
      • Shareholdings
    • Financial Information
      • Financial Results and Accounts
      • Public Periodic Information
      • Average supplier payment period
    • CNMV Filings
    • Analyst Coverage
    • Corporate Governance
      • General Shareholders Meeting
      • Board of Directors
      • Board Committees
      • Shareholder Agreements
      • Annual Corporate Governance Reports
      • Annual Director Remuneration Reports
    • Corporate Social Responsibility
  • News & Events
    • Press releases
    • Events
  • Contact
    • Contact
    • Email Alerts
    • Join us
  • General Shareholders Meeting
  • Board of Directors
  • Board Committees
  • Shareholder Agreements
  • Annual Corporate Governance Reports
  • Annual Director Remuneration Reports

Corporate Governance

  • General Shareholders Meeting
  • Board of Directors
  • Board Committees
  • Shareholder Agreements
  • Annual Corporate Governance Reports
  • Annual Director Remuneration Reports

Breadcrumb

  1. Home
  2. Investors
  3. Corporate Governance
  4. Board of Directors

Board of Directors

  • Carlos Buesa

    President (Executive Director)
  • Manuel López-Figueroa

    Board Member (Independent Director)
  • Luis Sánchez Quintana

    Board Member (Independent Director)
  • Konstantinos Alataris

    Board Member (Independent Director)
  • Montserrat Vendrell

    Board Member (Independent Director)
  • Pierre Beaurang

    Board Member (Independent Director)
Regulations of the Board of Directors
Regulations of the Board of Directors (Spanish)
Logo Oryzon
  • Company
    • Overview
    • Strategy
    • Team
  • Epigenetics
    • Epigenetics
    • LSD1
  • Programs
    • Pipeline
    • Iadademstat
    • Vafidemstat
    • Collaborations
    • Publications
  • Patients
    • Clinical Trials
  • Investors
    • Share Information
    • Financial Information
    • CNMV Filings
    • Analyst Coverage
    • Corporate Governance
    • Corporate Social Responsibility
  • News & Events
    • Press releases
    • Events
  • Contact
    • Contact
    • Email Alerts
    • Join us
  • © Oryzon Genomics, S.A. - All Rights Reserved

    • Legal
    • Privacy Policy
    • Cookie Policy
    • Ethics Channel